← Back to Search

Intensive Clinic Management (ICM) for Hypertension (TEAMS-BP Trial)

N/A

Waitlist Available

Led By Cheryl Bushnell, MD

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 month

Awards & highlights

TEAMS-BP Trial Summary

This trial compares two approaches to managing BP after stroke: Telehealth Monitoring vs Clinic Management. The goal is to find which is better at controlling BP and helping patients manage it.

Eligible Conditions

Secondary Hypertension

TEAMS-BP Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of participants with 3-month SBP control

Secondary outcome measures

Mean change in Partners in Health Scale (PIH) score at 3 months

Mean change in systolic blood pressure (SBP) at 3 months

Proportion of participants attending both visits among those who are randomized in the study

+5 more

TEAMS-BP Trial Design

2Treatment groups

Experimental Treatment

Group I: Intensive tailored telehealth management (ITTM)Experimental Treatment1 Intervention

Group II: Intensive Clinic Management (ICM)Experimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Intensive tailored telehealth management (ITTM)

2022

N/A

~80

Intensive Clinic Management (ICM)

2022

N/A

~80

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor

1,241 Previous Clinical Trials

1,004,163 Total Patients Enrolled

20 Trials studying Hypertension

34,408 Patients Enrolled for Hypertension

Cheryl Bushnell, MDPrincipal InvestigatorWake Forest Health Sciences

4 Previous Clinical Trials

1,705 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it feasible to join the clinical trial at this point in time?

"Per the information posted on clinicaltrials.gov, this research endeavour is actively recruiting participants. This trial was initially published on October 11th 2022 and recently revised on October 28th 2022."

Answered by AI

Does this experimental protocol permit elderly participants?

"This trial's admission requirements call for participants aged between 18 and 75. Sub-18s have 54 studies open to them, whereas individuals 65+ are eligible for 662 different clinical trials."

Answered by AI

What are the eligibility criteria for joining this clinical study?

"This clinical trial seeks 100 individuals with secondary hypertension who are aged between 18 and 75. To qualify, candidates must demonstrate a history of ischemic stroke or spontaneous haemorrhagic stroke; be proficient in English or Spanish; agree to install and use physical activity monitoring software on their phone; give written consent for the study, have access to a functioning smartphone with data connectivity, as well as commit to attending all required visits."

Answered by AI

How many participants are currently enrolled in this research project?

"Affirmative. According to the clinicaltrials.gov listing, this experiment is still enrolling participants and requires 100 volunteers at a single location. The trial was initially posted on October 11th 2022 with its last update occurring 17 days later on October 28th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Telehealth-Enhanced Assessment and Management After Stroke-Blood Pressure

2022. "Telehealth-Enhanced Assessment and Management After Stroke-Blood Pressure". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05539443.